Health Catalyst Inc (NASDAQ:HCAT) currently has a daily average trading volume of 803.89K but it saw 465545 shares traded in last market. With a market cap of 269.61M USD, the company’s current market price of $3.84 came rising about 2.40 while comparing to the previous closing price of $3.75. In past 52 weeks, the stock remained buoying in the range of price level as high as $9.24 and as low as $3.56. In the recent trading on the day, stock has struck highest price mark of $3.61 while lowest mark touched by it was $3.885.
Taking a look at 20-day trading activity of Health Catalyst Inc (HCAT) gives us an average price of $4.16, while its current price level is -58.44% below from 52-week high level whereas it is 7.87% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $4.57 while that of 200 days or SMA-200 reads an average of $6.68. A closer look into the stock’s movement over the week reveals that its volatility is standing at 8.79% during that period while stretching the period over a month that decreases to 7.82%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 38.82 which implies that the stock is in neutral territory.
KeyBanc Capital Markets upgraded its recommendation for the stock as a “Overweight” from “Sector Weight” on January 08, 2025 while assigning a price target of $9.
Over the week, HCAT’s stock price is moving 0.26% up while it is -14.86% when we observe its performance for the past one month. Year-to-date it is -45.69% down and over the past year, the stock is showing a downside performance of -30.56%.
The company is expected to be releasing its next quarterly report on 2025-Feb-25, for which analysts forecasted an EPS of 0.01 while estimate for next year EPS is 0.29. In next quarter, company is expected to be making quarterly sales of $82.93M as analysts are expecting the sales for current fiscal year at $334.15M and seeing the company making $366.72M in sales next year. Moreover, analysts are in estimates of $79.16M for current-quarter revenue.
Currently, Health Catalyst Inc’s total number of outstanding shares is 70.21M with 3.46% of that held by the insiders while 79.97% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -13.05% and return on equity (ROE) at -18.99%. It has a 9.10 of forward P/E ratio. Stock’s beta reads 1.58. Stock has a price to book (P/B) ratio of 0.67 while price to sale or P/S ratio amounts to 0.88. Its return on asset (ROA) is -8.91% on average.
